Relationship between the blood coagulation-fibrinolysis system and the subclinical indicators of arteriosclerosis in a healthy male population

Journal of Epidemiology

Volumn 10, Issue 1, 2000, Pages 34-41

  Nishiwaki, Yuji ^a   Takebayashi, Toru ^a   Omae, Kazuyuki ^a   Ishizuka, Chizuru ^a   Nomiyama, Tetsuo ^a   Sakurai, Haruhiko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Coagulation fibrinolysis system; Cross sectional study

Indexed keywords

BLOOD CLOTTING FACTOR;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; ARTICLE; BLOOD; BLOOD PRESSURE; CAROTID ARTERY; CROSS-SECTIONAL STUDY; DOPPLER FLOWMETRY; ECHOGRAPHY; FIBRINOLYSIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; BLOOD COAGULATION FACTORS; BLOOD PRESSURE; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 33846925424     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.10.34     Document Type: Article

References (26)

1. Tohgi H, Takahashi H, Chiba K, Tamura K. Coagulationfibrinolysis system in poststroke patients receiving antiplatelet medication. Stroke, 1993 ; 24: 801-804.
2. Lassila R, Peltonen S, Lepantalo M, et al. Severity of peripheral arteriosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb, 1993 ; 13 : 1738-1742.
3. Johnson O, Mellbring G, Nilsson T. Defective fibrinolysis in survivors of myocardial infarction. International J Cardiol, 1984 ; 6: 380-382.
4. Margaglione M, Di Minno G, Grandone E, et al. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of isché mie stroke. Arterioscler Thromb, 1994 ; 14: 1741-1745.
5. Takano K, Yamaguchi T, Uchida K. Markers of a hypercoagulable state following acute isché mie stroke. Stroke, 1992; 23: 194-198.
6. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet, 1993 ; 341: 1165-1168.
7. Ridker PiM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet, 1994 ; 343: 940-943.
8. Omae K, Takebayashi T, Nomiyama T, et al. Cross-sectional observation of the effects of carbon disulfide on arteriosclerosis in rayon manufacturing workers. Occup Environ Med, 1998 ; 55 : 468-472.
9. Takebayashi T, Omae K, Ishizuka C, Nomiyama T, Sakurai H. Cross-sectional observation of the effects of carbon disulfide on the nervous system, endocrine system, and subjective symptoms in rayon manufacturing workers. Occup Environ Med, 1998 ; 55 : 473-479.
10. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation, 1989 ; 80: 78-86.
11. Aral C, Abe N, Takeuchi K, et al. Comparison between antemortem PWV values and postmortem tissues -in relation to atherome, calcification, and intimo-medial elastin and collagen-. J Jpn Atheroscler Soc, 1985 ; 12 : 14191426.(in Japanese)
12. Maeda S. Application of a brief questionaire for the behavior pattern survey. Type A, 1991 ; 2 : 33-40.(in Japanese)
13. Paramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor -relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemostas, 1985 ; 54 : 713-716.
14. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with arteriosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas, 1995 ; 73 : 374-379.
15. Fowkes FGR, Lowe GDO, Housley E, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet, 1993 ; 342 : 84-86.
16. Speiser W, Speiser P, Minar E, et al. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res, 1990 ; 59 : 77-88.
17. Goto M, Kato Y. Hypercoagulable state indicates an additional risk factor for arteriosclerosis in Werner's syndrome. Thromb Haemostas, 1995 ; 73 : 576-578.
18. Hamsten A, Wiman B, Faire UD, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med, 1985 ; 313 : 1557-1563.
19. Hamsten A, Faire UD, Walldius G, et al. Plasminogen activator inhibitor in plasma : risk factor for recurrent myocardial infarction. Lancet, 1987 ; 2 : 3-8.
20. Jansson JH, Nilsson TK, Olofsson BO. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J, 1991 ; 12: 157-161.
21. Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease a 7-year follow-up. Circulation, 1993 ; 88 : 20302034.
22. Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early arteriosclerosis. The ARIC Study. Arteriosclerosis Risk in Communities Study. Circulation, 1995 ; 91 : 284-290.
23. Vaziri ND, Smith DHG, Winer RL, et al. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. J Am Soc Nephrol, 1993 ; 4: 222-228.
24. Alessi MC, Juhan-Vague I, Declerck PJ, et al. Correlations between t-pa and pai-1 antigen and activity and t-pa/pai-1 complexes in plasma of control subjects and of patients with increased t-pa or pai-1 levels. Thromb Res, 1990 ; 60: 509-516.
25. Philips M, Juul AG, Seimer J, Lind B, Thorsen S. A specific immunologie assay for functional plasminogen activator inhibitor 1 in plasma -standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease. Thromb Haemostas, 1992 ; 68 : 486-494.
26. Kohriyama T, Yamaguchi S, Tanaka E, Yamamura Y, Nakamura S. Coagulation and fibrinolytic parameters as predictors for small-vessel disease revealed by magnetic resonance imaging of the brain. Rinsho Shinkeigaku Clin Neural, 1996 ; 36: 640-647. (in Japanese)